HepatoScore-14: Measures of biological heterogeneity significantly improve prediction of hepatocellular carcinoma risk

BACKGROUND & AIMS: Therapeutic, clinical trial entry and stratification decisions for hepatocellular carcinoma (HCC) are made based on prognostic assessments, using clinical staging systems based on small numbers of empirically selected variables that insufficiently account for differences in bi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Hepatology
Asıl Yazarlar: Morris, Jeffrey S., Hassan, Manal M., Zohner, Ye Emma, Wang, Zeya, Xiao, Lianchun, Rashid, Asif, Haque, Abedul, Abdel-Wahab, Reham, Mohamed, Yehia A., Ballard, Karri L., Wolff, Robert A., George, Bhawana, Li, Liang, Allen, Genevera, Weylandt, Michael, Li, Donghui, Wang, Wenyi, Raghav, Kanwal, Yao, James, Amin, Hesham M., Kaseb, Ahmed Omar
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7956911/
https://ncbi.nlm.nih.gov/pubmed/32931023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.31555
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller